Women who use the antidepressant drug Zoloft during pregnancy are more likely to give birth to children with serious and potentially fatal heart defects or other congenital birth defects. The Food and Drug Administration has warned that the use of Zoloft while pregnant—especially during the third trimester—could cause harm to the fetus through congenital birth defects.
According to a February 2006 study published by the New England Journal of Medicine, women who take antidepressants such as Zoloft during the third trimester of pregnancy are six times more likely to give birth to a child with persistent pulmonary hypertension of the newborn (PPHN), a serious and potentially fatal circulatory condition.
The use of Zoloft has also been linked to a risk of other birth defects. A 2007 study published by the NEJM found that mothers who take Zoloft during pregnancy are twice as likely to give birth to children with heart defects, including ventricular outflow defects and septal defects. Researchers have linked Zoloft to an increased risk of other congenital birth defects, including omphalocele (organs protruding from the belly button), craniosynostosis (early closing of sutures in the skull) and anencephaly (parts of the brain and skull missing).
If you or a loved one used Zoloft or other antidepressants during pregnancy and gave birth to a child with PPHN or other birth defects, contact the lawyers at Hissey Kientz, LLP to learn more about your legal rights. You can reach us by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form to the right of this page. For more information, feel free to visit the Hissey Kientz, LLP website dedicated to Zoloft birth defects lawsuits.